Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary …
AH Diacon, R Dawson… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Bedaquiline is a new antituberculosis agent targeting ATP synthase. This randomized,
double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients …
double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients …
[HTML][HTML] Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive …
AH Diacon, R Dawson… - Antimicrobial Agents …, 2013 - ncbi.nlm.nih.gov
Bedaquiline is a new antituberculosis agent targeting ATP synthase. This randomized,
double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients …
double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients …
[PDF][PDF] Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive …
AH Diacon, R Dawson, F Von Groote-Bidlingmaier… - 2013 - academia.edu
MATERIALS AND METHODS Patients and setting. This was a two-center, double-blinded,
centrally randomized phase II trial investigating the EBA, safety, tolerability, and …
centrally randomized phase II trial investigating the EBA, safety, tolerability, and …
Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary …
AH Diacon, R Dawson… - Antimicrobial …, 2013 - pubmed.ncbi.nlm.nih.gov
Bedaquiline is a new antituberculosis agent targeting ATP synthase. This randomized,
double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients …
double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients …
Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary …
AH Diacon, R Dawson, G Symons, A Venter… - Antimicrobial Agents …, 2013 - europepmc.org
Bedaquiline is a new antituberculosis agent targeting ATP synthase. This randomized,
double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients …
double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients …
[PDF][PDF] Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive …
AH Diacon, R Dawson, F Von Groote-Bidlingmaier… - 2013 - Citeseer
MATERIALS AND METHODS Patients and setting. This was a two-center, double-blinded,
centrally randomized phase II trial investigating the EBA, safety, tolerability, and …
centrally randomized phase II trial investigating the EBA, safety, tolerability, and …
[PDF][PDF] Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive …
AH Diacon, R Dawson, F Von Groote-Bidlingmaier… - 2013 - tballiance.org
MATERIALS AND METHODS Patients and setting. This was a two-center, double-blinded,
centrally randomized phase II trial investigating the EBA, safety, tolerability, and …
centrally randomized phase II trial investigating the EBA, safety, tolerability, and …
[引用][C] Randomized dose-ranging study of the 14-day early bactericidal activity of Bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary …
AH Diacon, R Dawson, F von Groote-Bidlingmaier… - 2013 - scholar.sun.ac.za
Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary …
AH Diacon, R Dawson, F Groote-Bidlingmaier… - 2013 - cabidigitallibrary.org
Bedaquiline is a new antituberculosis agent targeting ATP synthase. This randomized,
double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients …
double-blinded study enrolling 68 sputum smear-positive pulmonary tuberculosis patients …
[引用][C] Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive …
AH DIACON, R DAWSON, H WINTER… - Antimicrobial …, 2013 - pascal-francis.inist.fr
Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207)
in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis CNRS Inist …
in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis CNRS Inist …